InvestorsHub Logo
Followers 11
Posts 306
Boards Moderated 0
Alias Born 09/18/2018

Re: None

Wednesday, 01/09/2019 10:32:02 AM

Wednesday, January 09, 2019 10:32:02 AM

Post# of 54907
No PR on this appointment, Chief Development Officer.

This makes three of the senior leadership formerly of Pfizer/Wyeth who are now a part of PRED. Sleeping Giant IMO.

"Bruce Forrest, M.D., was appointed Chief Development Officer in November of 2018. Prior to joining our Company, ...From 2009 to 2010, Dr. Forrest was Senior Vice President, Vaccine Clinical Research Transition, Pfizer Vaccine Research, where he led the strategic and operational integration of the former Wyeth Vaccine Research & Development with the global Pfizer Vaccine Research organization, including structuring Japan, China and Asia-Pacific activities. Dr. Forrest was Senior Vice President, Late Phase Programs, Vaccines R&D, Wyeth Research at Wyeth Pharmaceuticals from 1997-2009, where he was responsible for all late phase development activities supporting both clinical and pharmaceutical science development activities for vaccines in the Wyeth pipeline. Dr. Forrest earned a Bachelor of Science in Medicine from the University of Adelaide School of Medicine and an MBA from Warwick Business School."